APA (7th ed.) Citation

JX, Q., TC, W., LP, A., AY, C., DS, T., RZ, Y., . . . ME, S. (2015). Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311). Journal of medicinal chemistry, 58(22), 9010. https://doi.org/10.1021/acs.jmedchem.5b01363

Chicago Style (17th ed.) Citation

JX, Qiao, et al. "Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)." Journal of Medicinal Chemistry 58, no. 22 (2015): 9010. https://doi.org/10.1021/acs.jmedchem.5b01363.

MLA (9th ed.) Citation

JX, Qiao, et al. "Triphenylethanamine Derivatives as Cholesteryl Ester Transfer Protein Inhibitors: Discovery of N-[(1R)-1-(3-Cyclopropoxy-4-fluorophenyl)-1-[3-fluoro-5-(1,1,2,2-tetrafluoroethoxy)phenyl]-2-phenylethyl]-4-fluoro-3-(trifluoromethyl)benzamide (BMS-795311)." Journal of Medicinal Chemistry, vol. 58, no. 22, 2015, p. 9010, https://doi.org/10.1021/acs.jmedchem.5b01363.